Get In Touch

Industrial News

News
Hot products
Glutathione
Glutathione
Basic Info. Glutathione is a substance made from the amino acids glycine, cysteine, and glutamic acid. It is produced by the liver and involved in many body processes. Glutathione is involved in tissue building and repair, making chemicals and proteins needed in the body, and in immune system function. ...
GHK-CU
GHK-CU
Basic Info. GHK-CU is a natural copper binding peptide composed of tripeptides (glycine, L-histidine, and L-lysine) and copper ions. GHK-CU is a beneficial skin care and beauty ingredient that can promote collagen production, accelerate wound healing, improve skin elasticity, and has antioxidant and anti-inflammatory effects. It is widely used in anti-aging products, wound care products, and hair care products. When using GHK-CU products, pay attention to allergic reactions and choose the appropriate concentration and product according to personal circumstances. ...
Alprostadil
Alprostadil
Basic Info. Alprostadil is in a class of medications called vasodilators. It works by relaxing the muscles and blood vessels in the penis to keep enough blood in the penis so that an erection can occur. Alprostadil does not cure erectile dysfunction or increase sexual desire. ...
NAD
NAD
Basic Info. NAD, the full name of nicotinamide adenine dinucleotide, is an important coenzyme that participates in a variety of metabolic processes in cells, such as energy production, DNA repair, and cell signaling. NAD usually exists in two forms, NAD+ and NADH, which play an important role in electron transfer in cells. NAD is an important coenzyme that participates in a variety of metabolic processes in cells and is essential for health. By supplementing NAD+ or NMN, the level of NAD+ in the body can be increased, thereby improving health and delaying aging. ...
Mazdutide
Mazdutide
Basic Info. Mazdutide is a dual  agonist  of the GLP-1 receptor and glucagon receptor. It is an analog of oxyntomodulin (OXM).  The drug is developed by Eli Lilly and is currently in multiple Phase III studies.  In May 2025, a result of Phase III study has shown that once-weekly mazdutide led to clinically relevant reductions in body weight in Chinese adults with overweight or obesity. ...

Subscribe for the latest news. Stay updated on the latest trends.